Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
UB-941 by UBI Pharma for Solid Tumor: Likelihood of Approval
UB-941 is under clinical development by UBI Pharma and currently in Phase II for Solid Tumor. According to GlobalData, Phase...